Dr. Erwin Erfe

2 claims checked by other fact-checking organisations, from 2022 to 2022. The ratings are theirs, in their own words.

Checked by Vera Files4 Aug 2022PhilippinesFilipino

“Ang clinical trial na kinasasangkutan ng 10,025 bata na may edad 2 hanggang 14 na taong gulang, ay nagpahiwatig ng "napakababang" 56% na efficacy rate para sa Dengvaxia vaccine.”

Vera Files rated this: Nangangailangan ng konteksto

Vera Files says: Noong Hulyo 14, iniutos ng World Health Organization (WHO) na ang mga bakuna ay kailangang magkaroon ng “high efficacy rate na 50% o mas mataas.” Binanggit ng WHO na ang Dengvaxia ay may efficacy rate na humigit-kumulan…

Checked by Vera Files4 Aug 2022Philippines Health

Dr. Erwin Erfe

“The clinical trial which involved 10,025 children aged 2 to 14 years old, indicated a “very low” 56% efficacy rate for Dengvaxia vaccine.”

Vera Files rated this: Needs context

Vera Files says: As of July 14, the World Health Organization (WHO) requires vaccines to have a “high efficacy rate of 50% or above. The WHO noted that Dengvaxia has an efficacy rate of about 80% among children within the age range of 9…